The operating beat is substantial, but memory supplied most incremental sales and growth absorbed cash. Our three valuation routes support a base around $60. Wait for better cash conversion or a margin of safety near $48. Preferred participation, note exchanges and the diluted denominator matter to common holders.
Author probabilities and assumptions; not forecasts supplied by the company.
| Measure | Value |
|---|---|
| Bear | 35.00 |
| Base | 60.00 |
| Bull | 100.00 |
| Weighted | 60.50 |
| Reference close | 64.21 |
| Scenario | Probability | 12-month value | vs $64.21 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $35.00 | −45% | Growth or conversion disappoints; multiple contracts. | $3.75 adjusted EPS ×9=$33.75, rounded to$35. |
| Base | 50% | $60.00 | −7% | Guided growth with normalized cash investment. | DCF$59.43 and EV/EBIT$58.95; EPS cross-check$66.75; base rounded$60. |
| Bull | 20% | $100.00 | +56% | Upper guide plus durable platform economics. | $5.15 adjusted EPS ×20=$103, rounded conservatively to$100. |
| Computed expected value:30%×$35+50%×$60+20%×$100=$60.50. | |||||
| Signpost | Now (Q4 FY2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Revenue growth | FY27 guide40% ±10pp | At least30% | Below30% | Jan31,2027 review |
| Quarterly operating cash | Q4 -$163.1M | Positive cash flow | Below -$100M | Jan31,2027 review |
| Inventory endpoint proxy | 166 days | Below140 days | Above180 days | Jan31,2027 review |
| GAAP operating margin | Q4 12.3% | Above13% | Below10% | Jan31,2027 review |
| Diluted common planning shares | FY27 guide63M | At or below63M | Above66M without offsetting value | Jan31,2027 review |
| Valuation margin | Price$64.21 / base$60 | Price at or below$48 | Price above$80 without higher value | Oct30,2026 review |
These are author review dates and thresholds, not announced earnings-release dates. Reassess alongside actual filings.
A closing quote, not an invented earnings reaction
Penguin Solutions has become an AI infrastructure story, but its shares still represent a mixed business with memory products, systems and services, and LED components. That distinction matters when deciding what multiple to pay. The current release is a large operating improvement. It is also a test of whether rapid growth can turn into cash without requiring repeated financing or a larger common-share denominator. Our HOLD is a judgment about that conversion and the price paid, not a prediction that demand will disappear.
The price reference is the October 6 regular-session close of $64.21 from FMP. The release date is independently verified in the SEC earnings exhibit, but accessible primary publication metadata did not establish its exact clock. We therefore do not label the regular-session gain an earnings reaction. The quote, market capitalization and float are provider observations with their own timestamp; they are not synchronized measures of the post-financing capital structure. Readers should use the valuation denominator described below rather than multiply a stale share count into a false precision.
The historical chart is useful context for how much optimism is already in the price. It cannot establish what buyers knew at any particular instant. Our reaction series uses the next trading close divided by the event-day close for every release, a consistent one-day proxy rather than an exact release-session return. The current event has no completed next-close observation at this cutoff. Missing returns stay missing. We do not turn a conference-call time, a filing acceptance time or an expected calendar slot into a release timestamp.
| Date | Close |
|---|---|
| 2025-07-01 | $20.17 |
| 2025-07-31 | $23.57 |
| 2025-08-29 | $24.13 |
| 2025-09-30 | $26.28 |
| 2025-10-29 | $22.39 |
| 2025-11-28 | $20.23 |
| 2025-12-30 | $20.03 |
| 2026-01-30 | $19.21 |
| 2026-03-03 | $18.95 |
| 2026-04-01 | $18.25 |
| 2026-05-01 | $31.24 |
| 2026-06-02 | $70.65 |
| 2026-07-02 | $61.47 |
| 2026-08-03 | $52.60 |
| 2026-09-01 | $47.59 |
| 2026-10-01 | $54.98 |
| Release date | Next-close proxy |
|---|---|
| 2026-10-06 | Pending / unavailable |
| 2026-07-07 | +25.13% |
| 2026-04-01 | +13.37% |
| 2026-01-06 | −13.78% |
| 2025-10-07 | −16.00% |
| 2025-07-08 | +10.57% |
| 2025-04-02 | Pending / unavailable |
| 2025-01-08 | Pending / unavailable |
| 2024-10-15 | Pending / unavailable |
| Computed uniform clock proxy. No current print reaction is asserted. | |
A material beat with a changing mix
Quarterly revenue was $566.7 million, up 67.7% year over year. Adjusted diluted earnings were $1.00 versus $0.43 a year earlier. The provider estimate snapshot was $521.0 million of revenue and $0.772 of adjusted EPS, making the reported beats 8.8% and 29.5%, respectively. These are comparisons against the captured estimate record, not a claim that every analyst used the same definitions or revised at the same time.
The improvement is visible before adjustments. GAAP operating income reached $69.5 million against $12.4 million a year earlier. Gross profit increased while operating expenses grew much more slowly than sales, producing operating leverage. Yet the gross-margin percentage slipped from the year-earlier level: a larger revenue base does not mean each dollar carries a better gross spread. That is why we separate volume, mix, gross profit and operating leverage rather than treating the earnings multiple as a single explanation.
Management now guides fiscal 2027 revenue growth to 40%, plus or minus ten percentage points, and adjusted EPS to $4.45, plus or minus $0.70. The release describes a roughly $2.43 billion revenue midpoint compared with the earlier preliminary $2.17 billion view. Applying 40% to the exact reported fiscal 2026 base produces $2.424 billion; the difference from $2.43 billion is rounding, not another guidance change. The wide range is material. A model that uses only the midpoint hides the execution risk in supplier availability, project timing and the memory cycle.
The FY2026 10-K was not yet in the source set. Current annual statements come from the unaudited earnings exhibit. That is enough to analyze the verified print, with a clear obligation to revisit the annual footnotes when filed. It is not permission to assume missing segment profit, contract economics or tax detail.
| Metric | $M except EPS | Year earlier | Prior quarter |
|---|---|---|---|
| Revenue | 566.685 | 337.922 | 478.713 |
| GAAP operating income | 69.462 | 12.448 | 50.863 |
| Adjusted operating income | 89.796 | 39.170 | 64.384 |
| GAAP EPS | 1.29 | 0.11 | 0.68 |
| Adjusted EPS | 1.00 | 0.43 | 0.84 |
| Period | Revenue |
|---|---|
| Q4 2024 | 311.15 |
| Q1 2025 | 341.10 |
| Q2 2025 | 365.52 |
| Q3 2025 | 324.25 |
| Q4 2025 | 337.92 |
| Q1 2026 | 343.07 |
| Q2 2026 | 343.00 |
| Q3 2026 | 478.71 |
| Q4 2026 | 566.68 |
| Period | YoY growth |
|---|---|
| Q1 FY2026 | 0.58 |
| Q2 FY2026 | −6.16 |
| Q3 FY2026 | 47.64 |
| Q4 FY2026 | 67.70 |
Memory leads the reported bridge
Integrated Memory generated $340.8 million of quarterly sales, compared with $132.2 million a year earlier. That is 157.9% growth. Its $208.6 million increase contributed 91.2% of the consolidated revenue increase. Advanced Computing grew to $154.0 million from $138.3 million, while Optimized LED reached $71.9 million from $67.4 million. The arithmetic is central to the thesis: the current reported growth is overwhelmingly a memory contribution, even while the forward narrative emphasizes AI infrastructure wins.
This is not an argument that the new customer wins have no value. The release identifies six new AI Infrastructure data-center customers in the quarter, including four neocloud providers; seventeen new customers and twelve expansions were reported for the full year. Those are encouraging activity indicators. They are not disclosed backlog dollars, contracted Penguin revenue, cash receipts, or guaranteed future margins. In particular, the customer's own signed compute contracts must not be described as Penguin's revenue backlog. The Norway deployment references 36,000 GPUs, but the release does not disclose Penguin's contract value or profit on that engagement.
The latest filed quarterly segment-profit disclosure is Q3, ending May 29. Its management non-GAAP presentation shows an Advanced Computing loss of $1.9 million, Memory income of $62.2 million and LED income of $4.1 million. The segment footnote also presents a different Advanced Computing measure including a $5.8 million insurance recovery; those measures must not be mixed. We use the explicit management non-GAAP presentation and label its period. Q4 segment profit is unavailable in the current release, so no margin is allocated by analogy.
The next evidence needed is therefore specific: convert the larger customer set into profitable Advanced Computing revenue while retaining Memory economics as input pricing and availability change. A customer count can rise before cash arrives. A differentiated service relationship could deserve a stronger multiple, but that premium must be earned in revenue quality and recurring economics, not assigned to all hardware sales automatically.
| Period | Q4 FY2025 | Q4 FY2026 |
|---|---|---|
| Advanced Computing | 138.34 | 154.04 |
| Integrated Memory | 132.16 | 340.78 |
| Optimized LED | 67.43 | 71.86 |
| Measure | Value |
|---|---|
| Advanced Computing | −1.88 |
| Integrated Memory | 62.19 |
| Optimized LED | 4.08 |
| Measure | Value |
|---|---|
| New in Q4 | 6.00 |
| Q4 neocloud subset | 4.00 |
| New in FY2026 | 17.00 |
| Expanded in FY2026 | 12.00 |
Tax, financing and participation change the answer
The operating improvement is real, but the route from operating income to EPS is unusual this quarter. Starting from $69.462 million of GAAP operating income, net interest income adds $0.980 million and other non-operating expense removes $33.028 million, leaving $37.414 million of pretax income. A $57.595 million income-tax benefit then lifts consolidated net income to $95.009 million. After noncontrolling interests, preferred dividends and the allocation to participating securities, $81.267 million is available to common stockholders under the reported presentation. Each step has a different economic meaning.
The tax benefit is especially important because it makes GAAP EPS higher than adjusted EPS. We do not call all of that reported profit a recurring operating run rate. The cash-flow reconciliation includes a substantial deferred-tax adjustment, and the annual balance sheet shows a larger deferred-tax asset. Without the new annual tax footnote, we do not assign the benefit to an unsupported specific cause or promise it will recur. The non-GAAP reconciliation removes tax effects alongside the other identified adjustments; this is a reason to inspect the bridge, not to dismiss either accounting measure.
The financing-related inducement expense of $33.248 million is also not a normal product margin. It relates to conversions of older notes. Excluding it may help compare operating periods, but the associated capital transaction is economically consequential: the July filing describes cash plus approximately 8.7 million common shares exchanged for old notes. Calling the expense noncash would not make that dilution free.
Preferred dividends and participating-security allocations explain why consolidated net income cannot simply be divided by a provider common-share count. The company reports separate GAAP and adjusted diluted denominators, with adjustments for securities and capped calls. Our EPS route uses the company's adjusted common EPS directly. Our enterprise routes handle preferred conversion explicitly and disclose the denominator, avoiding a second preferred deduction on top of conversion shares.
| Item | $M |
|---|---|
| Operating income | 69.462 |
| Pretax | 37.414 |
| Consolidated income | 95.009 |
| Common income | 81.267 |
| Period | GAAP parent income | Adjusted parent income |
|---|---|---|
| Q4 FY2025 | 9.43 | 28.84 |
| Q3 FY2026 | 44.69 | 52.25 |
| Q4 FY2026 | 93.20 | 71.44 |
| FY2026 bridge | $M |
|---|---|
| GAAP operating income | 165.596 |
| Net non-operating expense | −13.673 |
| Pretax income | 151.923 |
| Tax benefit | 33.865 |
| Consolidated income | 185.788 |
| Noncontrolling interest | −5.173 |
| Preferred dividends | −12.133 |
| Participating allocation | −17.394 |
| Common income | 151.088 |
Cash conversion is the principal weakness
The same nine checks yield a mixed picture. Stock compensation is manageable relative to current sales, and reported operating leverage is strong. Cash conversion is weak, the tax rate is distorted by a benefit, and the common-share capital structure requires care. A single composite quality score would conceal these differences. We show the checks separately so a reader can decide which weaknesses can reverse and which belong in the valuation permanently.
Receivables increased to $796.3 million and inventories to $748.8 million. Using ending balances divided by current-quarter sales or cost of sales, multiplied by 91 days, produces rough collection and inventory proxies, not audited days-sales-outstanding or average-balance turnover. The end-point method is deliberately labeled because rapid growth can make it look worse than an average-balance calculation. Even with that caveat, the cash absorption is large enough to matter. A claim of temporary investment needs subsequent collections and inventory shipment evidence.
For the year, receivables and inventory together consumed $982.0 million of cash. Higher payables and other liabilities funded a substantial part of that build. This funding can accompany legitimate growth, but supplier financing is not the same as customer cash conversion. If demand timing changes, inventory can remain while obligations come due. We would watch revenue growth together with cash flow and balance-sheet changes, not use any one line as proof of distress or success.
Reported FY2026 operating cash flow was negative $151.9 million. Subtracting $11.6 million of capital expenditures gives negative $163.5 million of free cash flow. This definition includes the cash effects of stock compensation through the accounts and does not add SBC back as free money in valuation. The latest annual earnings exhibit provides enough detail for the calculation; provider cash-flow fields currently contain zeros and must not be mistaken for zero investment. Primary statements override those incomplete records.
| Measure | Value |
|---|---|
| Stock compensation | 6.62 |
| Acquired amortization | 7.23 |
| Restructuring | 4.49 |
| Acquisition costs | 0.86 |
| Other | 1.14 |
| Period | Receivables / sales | Inventory / cost |
|---|---|---|
| Q4 FY2025 | 82.92 | 96.28 |
| Q1 FY2026 | 90.71 | 78.56 |
| Q2 FY2026 | 98.15 | 117.67 |
| Q3 FY2026 | 133.88 | 131.25 |
| Q4 FY2026 | 127.87 | 165.88 |
| Period | Operating cash | Free cash flow |
|---|---|---|
| 2024 | 77.19 | 57.76 |
| 2025 | 109.08 | 100.07 |
| 2026 | −151.91 | −163.48 |
A bigger cash balance does not erase dilution
Cash and equivalents ended the year at $647.2 million, against $789.0 million of current and long-term debt carrying value. That produces $141.7 million of net debt before operating leases. There is also $202.7 million of temporary equity representing convertible preferred stock and $16.4 million of noncontrolling interests. Our enterprise bridge treats operating leases as operating obligations already reflected in operating cash economics, rather than silently mixing a lease-inclusive provider debt number with an unadjusted EBIT multiple.
The July transaction issued $750 million of zero-coupon notes due in 2031. The absence of a regular coupon lowers near-term cash interest, but the principal obligation remains. Proceeds funded old-note repurchases, repayment of the revolver, capped calls and general purposes. The old-note exchange also issued approximately 4.7 million and 4.0 million common shares in the two transactions. This is why a static provider share count is an unreliable denominator for the new valuation.
The 2031 notes begin with a conversion price around $116.70; the capped calls initially cap protection at $175.05. Those thresholds are contract details, not a prediction that the shares will reach them. Capped calls reduce some potential dilution under specified conditions, cost cash, involve counterparties, and do not forgive principal. We retain the debt claim and do not add all note-conversion shares to the same scenario, which would count the same financing twice.
The preferred stock has a different economic claim. The annual report gives a $200 million original investment and a $32.81 initial conversion price. For the enterprise models, we assume conversion into approximately 6.10 million shares and add those to the 63 million guided diluted common planning denominator. We then do not also subtract preferred carrying value. This is a modeled as-converted case, not a statement that conversion has happened. Changes to conversion terms, participating distributions or the actual diluted denominator are explicit reasons to update the model.
| Measure | Value |
|---|---|
| Cash | 647.21 |
| Debt carrying value | 788.95 |
| Preferred carrying value | 202.71 |
| NCI | 16.44 |
| Cash-flow allocation FY2026 | $M |
|---|---|
| Operating cash flow | −151.914 |
| Capex | 11.569 |
| Common stock acquired | 74.427 |
| Preferred cash dividends | 12.233 |
| New notes | 750 |
| Capped-call purchases | 49.125 |
| Restricted cash advances | 93 |
| Buybacks include shares acquired for employee-related purposes; do not label the full number open-market repurchases. | |
Three routes, one cautious call
Our base fair value is $60, with a $35 to $100 scenario range and high uncertainty. At the $64.21 reference close, the price is slightly above our base case. The operating acceleration prevents a reflexively bearish conclusion, but cash conversion and financing complexity prevent a high-conviction BUY. We require a 20% margin below the base value, or about $48, unless new evidence supports a higher intrinsic value. This is an analytical decision rule, not a forecast of the next traded price.
The discounted cash-flow route starts with the exact FY2026 revenue base. Revenue grows 40%, 20%, 15%, 10% and 8% across FY2027–31. GAAP EBIT margins begin at 13.5%, rise to 14.5%, then stabilize at 15%. These are our assumptions, not company guidance beyond the first-year reference. Cash tax is 20%; depreciation and amortization are 2.5% of sales; capex is 1.8%; incremental working capital consumes 12% of each sales increase. GAAP EBIT retains stock compensation as an expense. The working-capital assumption requires a dramatic improvement from the latest cash absorption and is a principal model risk.
At a 12% discount rate and 3% terminal growth, the model produces about $4.265 billion of enterprise value. Subtracting $141.7 million net debt and $16.4 million NCI, then dividing by 69.10 million modeled shares, gives $59.43. Roughly 71% of enterprise value comes from terminal value. That dependence is why the sensitivity grid matters and why we publish a broad scenario range rather than pretending a cent-level output is accurate.
The earnings route is deliberately simpler: management midpoint adjusted EPS of $4.45 times an author-selected 15 multiple gives $66.75. This uses the company EPS after its stated common-holder allocations, with no extra debt or preferred subtraction. The third route applies 13 times modeled FY2027 GAAP EBIT of $325.5 million, using the guided gross-margin and expense midpoints; the same enterprise-to-common bridge gives $58.95. These routes cluster around the low sixties, so we round the base to $60. The market at $64.21 is already asking for much of that successful execution. It is not pricing a complete failure.
The bear case uses $3.75 adjusted EPS and a nine multiple, rounded to $35, with 30% weight. The base receives 50% at $60. The bull uses $5.15 and twenty times earnings, rounded conservatively to $100, with 20% weight. The probability-weighted value is $60.50. Probabilities and multiples are our judgments. They are not objective frequencies, and favorable guidance alone does not guarantee the bull case.
$4,264.6M enterprise value − $158.2M net debt/NCI, divided by 69.10M modeled shares = $59.43.
$4.45 FY2027 adjusted EPS × 15 = $66.75. Preferred/common allocations remain in company EPS.
($325.5M GAAP EBIT × 13 − $158.2M net debt/NCI) ÷ 69.10M modeled shares = $58.95.
| Discount rate | 2% | 3% | 4% |
|---|---|---|---|
| 11% | $61.52 | $67.73 | $75.72 |
| 12% | $54.63 | $59.43 | $65.43 |
| 13% | $49.02 | $52.80 | $57.43 |
| Model year | Sales $M | EBIT margin | FCFF $M |
|---|---|---|---|
| 2027 | 2424.1 | 13.5% | 195.7 |
| 2028 | 2908.9 | 14.5% | 299.6 |
| 2029 | 3345.2 | 15.0% | 372.5 |
| 2030 | 3679.7 | 15.0% | 427.2 |
| 2031 | 3974.1 | 15.0% | 469.4 |
| Author forecasts. FCFF includes explicit growth working-capital investment. | |||
Available targets are not post-print revisions
The captured FMP target consensus is $65, with a $40 low, $80 high and $75 median. Ratings show seven buys, one hold and one sell. Those summaries describe the provider record; they do not establish that each analyst has digested today’s release. The most recent target-news entries available in our pull were dated July. We therefore label the marks stale relative to the October results rather than narrating an overnight Street upgrade that we cannot verify.
The captured annual estimate for FY2027 revenue is approximately $2.212 billion, with four revenue analysts; EPS averages $3.386 across three estimates. Management’s updated revenue midpoint is higher, but the provider does not give a clean common estimate cutoff. The comparison is useful as a scale check, not a promise of future consensus revisions or a reliable measure of a same-definition EPS surprise. Revenue and earnings can have different analyst counts, and provider fiscal dates are standardized differently from Penguin’s actual last-Friday year-end.
Our $60 base is below the $65 mean target, while our earnings-multiple route is close to it. The disagreement is primarily about cash conversion and ownership economics, rather than denying sales growth. A reader who believes the memory cycle and project pipeline will support stronger margins with less working capital can justify a higher value; the bull case shows that possibility openly. A reader who sees supplier-funded inventory growth as less durable should lower the cash conversion assumption or increase the discount rate. Neither decision should be hidden inside a supposedly neutral consensus number.
| Measure | Value |
|---|---|
| Buy | 7.00 |
| Hold | 1.00 |
| Sell | 1.00 |
| Period | Captured consensus | Management midpoint |
|---|---|---|
| FY2027 | 2,212.41 | 2,424.06 |
| Firm | Published date | Target |
|---|---|---|
| Barclays | 2026-07-09 | $40 |
| Needham | 2026-07-08 | $80 |
| Stifel Nicolaus | 2026-07-08 | $75 |
| Stifel Nicolaus | 2026-06-02 | $66 |
| Goldman Sachs | 2026-01-13 | $25 |
| Stifel Nicolaus | 2025-10-06 | $31 |
| FMP target-news record. These are historical marks, not new October 6 recommendations. | ||
Reward the execution; test the conversion
Management deserves credit for the second-half acceleration and the higher forward view. The release ties the change to demand, product work, supply arrangements and new customer relationships. Those explanations are plausible and have measurable outcomes. They should be judged against subsequent revenue, margins, collections and financing needs rather than against the number of AI references in a presentation. The most useful scorecard separates selling activity from cash results.
Capital allocation is more ambiguous. A zero-coupon financing extends maturity and supplies liquidity, but common shares were issued in the old-note exchange and cash was spent on capped calls and share purchases. The company can have improved financing terms and dilution at the same time. The newly appointed CFO, Stephen Cumming, starts during a period when working-capital discipline and clear disclosure are especially valuable. The appointment is a disclosed personnel change, not evidence by itself of a financial-reporting problem.
We would ask five questions. How much of the receivables increase is tied to contractual payment schedules versus overdue balances? What portion of inventory is committed to identifiable customers, and what cancellation protection exists? How do service and software economics change the margin of the new AI infrastructure wins? What is the expected cash-conversion path under the new revenue guidance? How should investors reconcile the forward diluted-share guide with preferred participation, old-note exchange shares and capped-call treatment? Answers would reduce uncertainty more than another headline customer count.
| Area | Assessment | Evidence to grade next |
|---|---|---|
| Growth execution | Positive | Revenue and adjusted EPS beat captured estimates; higher FY27 outlook. |
| Mix disclosure | Mixed | Memory explains most current growth; Q4 segment profit awaited. |
| Cash discipline | Needs proof | Receivables and inventory rose sharply; FY cash flow negative. |
| Capital allocation | Mixed | Longer zero-coupon financing, but exchange dilution and capped-call cash cost. |
| Disclosure quality | Monitor | New annual footnotes, tax detail and diluted-share reconciliation needed. |
The strongest bull and bear cases
The strongest bull case is that Penguin is building relationships and supply capacity ahead of a much larger deployment cycle. If customers pay on schedule, inventory ships and recurring management services grow, today’s cash absorption could precede a sustained improvement in cash earnings. Memory strength would fund investment while Advanced Computing customer wins mature. Under that path, a multiple above our base earnings route can be reasonable. We do not discard this outcome merely because current free cash flow is negative.
The strongest bear case is that investors are paying an AI-platform multiple for a large cyclical memory contribution and hardware working-capital burden. Receivables may take longer to collect, inventory may become less valuable, and supplier terms may tighten. A tax benefit and adjusted earnings growth could mask weaker owner cash generation. If financing repeatedly increases the common denominator, company growth need not translate proportionately into value per share.
Our position sits between those cases: recognize the operating beat, retain high uncertainty, and demand measurable conversion before increasing the valuation. The risk table ranks execution and liquidity ahead of generic market volatility. An unexpected loss of a major customer or supplier could make the downside nonlinear; the annual report describes meaningful customer concentration and dependence on a limited supplier set. Historical FY2025 concentration is evidence of exposure, not a claim that those exact percentages describe today’s quarter.
| Risk | Likelihood | Impact | Evidence / mitigation |
|---|---|---|---|
| Working-capital conversion | High | High | FY2026 cash use; require collections and inventory normalization. |
| Memory price/mix reversal | Medium | High | Memory drives most current sales increase. |
| AI deployment timing | Medium | High | Customer wins do not disclose contract economics. |
| Share dilution / preferred claims | Medium | High | Old-note exchange shares; participating preferred stock. |
| Customer / supplier concentration | Medium | High | FY2025 top customer18.2%; memory customer14.1%. |
| Tax normalization | High | Medium | Large current benefit; recurring rate differs. |
| Execution / key personnel | Medium | Medium | New CFO and rapid operational scaling. |
Dates are checkpoints, not invented announcements
The next filing and operating updates can change the valuation without waiting for a full year of results. The pending FY2026 annual report should supply the audited notes behind cash restrictions, taxes, segment economics and financing. We treat that as a filing to monitor, with no fabricated publication date. Our dated signposts use calendar review checkpoints so the thesis can be tested even when the issuer has not announced the next earnings release.
The first business test is whether subsequent growth is accompanied by improved cash conversion. The second is whether Advanced Computing turns a growing customer set into disclosed profitable revenue. The third is whether the forward diluted-share and preferred assumptions match actual reporting. A missed checkpoint is a prompt to investigate, not an automatic trading rule. Stronger sales alone will not resolve all three questions.
We would consider upgrading the call if the cash evidence improves enough to support the model while the price offers the required margin of safety, or if new disclosed recurring economics justify raising fair value. We would lower the valuation if cash absorption remains severe, guidance weakens, inventory loses value, or additional financing changes the per-share economics. These conditions make the call falsifiable: the same evidence that supports a higher value must be allowed to weaken it.
| Checkpoint | Timing | Question |
|---|---|---|
| FY2026 10-K | When filed; monitor by Oct30,2026 | Audit notes, tax benefit, segment profit, capital structure. |
| Working-capital review | Jan31,2027 analytical checkpoint | Collections and inventory versus sales. |
| FY2027 outlook review | Jan31,2027 analytical checkpoint | Growth and margin assumptions still supported? |
| Midyear cash test | Apr30,2027 analytical checkpoint | Cumulative cash flow and share count. |
| Review dates are ours, not issuer-announced release dates. | ||
Every model choice stays visible
The financial dataset retains nine dated earnings exhibits, their structured statement tables, the latest filed quarterly and annual reports, the financing filing and current FMP snapshots. Primary statements govern when provider normalization conflicts with the filings. This matters here: current provider operating income, debt classifications, cash-flow investment fields and share counts do not all reproduce the new release correctly. Those original responses are preserved for provenance, not silently promoted into the model.
Dollar financial series are in millions unless a table explicitly says per share. Growth, margins, free cash flow, balance-sheet proxies, valuation and probability-weighted values are computed in the accompanying Python calculation. Free cash flow means reported operating cash flow less cash capital expenditure. It is not a company non-GAAP cash metric. Historical cash flow can include discontinued operations, which is marked in the annual chart. Quarter values are actual discrete-quarter amounts, with original comparative restatements preserved in the source tables.
The newest quarter’s segment-profit detail is not provided in the earnings release, so we use the latest disclosed Q3 management measure and label its date. Employee count is approximately 2,900 at the last annual report; unverified later counts are not backfilled from an unchanged provider profile. The company is now a Delaware Nasdaq common issuer following the completed June2025 redomiciliation. The prior annual report names Deloitte & Touche LLP and states that the foreign audit-inspection disclosure is not applicable. Historical Cayman domicile alone is not a current listing or audit failure.
Valuation uses assumptions that can be wrong. A twelve-percent discount rate and three-percent terminal growth rate are author judgments. The DCF retains stock compensation within GAAP operating profit and makes explicit capital-spending and working-capital assumptions. The as-converted preferred treatment avoids subtracting its carrying value a second time. We do not claim an audited fully diluted share count from the management planning guide. Earnings multiples are cross-checks, not substitutes for the cash-flow model. The source cutoff and limitations are part of the research, because hiding them would make the result appear more certain than the evidence warrants.
| Quarter | Sales | GAAP OI | Adj OI | GAAP EPS | Adj EPS |
|---|---|---|---|---|---|
| Q4 FY2024 | 311.148 | 8.791 | 33.739 | −0.46 | 0.37 |
| Q1 FY2025 | 341.102 | 17.356 | 40.918 | 0.10 | 0.49 |
| Q2 FY2025 | 365.519 | 18.488 | 49.090 | 0.09 | 0.52 |
| Q3 FY2025 | 324.251 | 9.843 | 38.474 | −0.01 | 0.47 |
| Q4 FY2025 | 337.922 | 12.448 | 39.170 | 0.11 | 0.43 |
| Q1 FY2026 | 343.071 | 19.582 | 41.528 | 0.04 | 0.49 |
| Q2 FY2026 | 342.999 | 25.689 | 45.254 | 0.58 | 0.52 |
| Q3 FY2026 | 478.713 | 50.863 | 64.384 | 0.68 | 0.84 |
| Q4 FY2026 | 566.685 | 69.462 | 89.796 | 1.29 | 1.00 |
| USD millions except EPS; original SEC earnings exhibits. | |||||
| Fiscal year | Revenue | OCF | Capex | FCF | SBC |
|---|---|---|---|---|---|
| 2024 | 1170.796 | 77.185 | 19.424 | 57.761 | 43.16 |
| 2025 | 1368.794 | 109.084 | 9.012 | 100.072 | 41.176 |
| 2026 | 1731.468 | −151.914 | 11.569 | −163.483 | 31.815 |
| Source | Document |
|---|---|
| Q4 FY2024 | SEC earnings submission |
| Q1 FY2025 | SEC earnings submission |
| Q2 FY2025 | SEC earnings submission |
| Q3 FY2025 | SEC earnings submission |
| Q4 FY2025 | SEC earnings submission |
| Q1 FY2026 | SEC earnings submission |
| Q2 FY2026 | SEC earnings submission |
| Q3 FY2026 | SEC earnings submission |
| Q4 FY2026 | SEC earnings submission |
| Annual structure | FY2025 10-K |
| Latest filed quarter | Q3 FY2026 10-Q |
| Financing | July17,2026 8-K |
| Market data | FMP stable endpoints; October6 capture; raw responses retained. |